Clinical study results: Effects on VLDL,
hemoglobin & glucose
% Reduction in VLDL
%
Improvement
in Hemoglobin
% Reduction in glucose
Statistical significance
13
• Statistical significance only with 250 mg BID
• One way ANOVA; p <0.001
Non-
significant
CONFIDENTIAL
Comparison of Sensoril® data to Lexapro® and Effexor® data
from literature - HAM-A/mHAM-A Day 0 – Day 60
Hamilton parameter: Initial vs 60-day
14
CONFIDENTIAL
